The subject of the contract is the supply of medicinal products accounted for from the package of drug programs and chemotherapy specified in 20 packages.

Pakiet No. 1: Alektynib 150 mg, at x224 kaps. - 288 on.

Package No. 10: Nintedanibum 150 mg x 60 caps. hard - 1992 op., Nintedanibum 100 mg x 60 caps. hard - 1392 op.

Pakiet Nr 11: Niwolumab 100 mg/10 ml x 1 fiol. - 344 op., Niwolumab 40 mg/4ml x 1 fiol. - 1704 on.

Pakiet Nr 12: Rituximabum 100 mg/10ml x 2 fiol. - 88 op., Rituximabum 500 mg/50ml x 1 fiol. - 120 on.

Pakiet No. 13: Entrektynib 200 mg on. x 90 kaps. - 32 on.

Pakiet No. 14: Osimertinib 40 mg x 30 tabl. - 96 op., Osimertinib 80 mg x 30 tabl. - 1048 on.

Pakiet Nr 15: Atezolizumabum 840mg/14ml x 1 fiolk. - 144 op., Atezolizumabum 1200mg/20ml x 1 fiolk. - 608 on.

Package No. 16: Nintedanib 100 mg x 120 caps. - 64 Op.

Pakiet Nr 17: Crizotynib 200mg x 60 caps. - 8 op., Crizotynib 250mg x 60 caps. - 16 op.

Pakiet No. 18: Omalizumab 150 mg/1ml, op. x 1 amp. Strzyk. - 1152 op., Omalizumab 75 mg/0.5ml, op. x 1 amp. Strzyk. - 48 on.

Pakiet No. 19: Ipilimumab 50mg/10 ml x 1 fiol. - 320 op., Ipilimumab 200mg/40 ml x 1 fiol. - 24 on.

Pakiet Nr 2: Dupilumab 200 mg, at x 2 amp. Strzyk. – 80 op., Dupilumab 300 mg, at x 2 amp. Strzyk. - 16 on.

Package No. 20: Pirfenidone 267 mg x 63 tabl. - 40 Op.

Pakiet No. 3: Erlotinib 100 mg, at x 30 tabl. - 10 op., Erlotinib 150 mg, at x 30 tabl. - 88 on.

Pakiet No. 4: Pirfenidone 267 mg x 252 tabl. - 624 op., Pirfenidone 801 mg x 84 tabl. - 1656 on.

Pakiet No. 5: Benralizumab 30 mg, at x 1 wstrzykiwacz - 360 op.

Pakiet Nr 6: Durwalumab 120 mg/2,4ml, on x 1 fiol. - 8 op., Durwalumab 500 mg/10ml, opx 1 fiol. - 480 on.

Pakiet No. 7: Pembrolizumab 100mg/4ml, op. x 1 fiol. - 3792 on.

Pakiet No. 8: Cemiplimab 350mg/7ml, op. x 1 fiol. - 224 on.

Package No. 9: Mepolizumab 100 mg x 1 autoinjector - 1400 op.